Programmed Death–Ligand 1 and Vimentin: A Tandem Marker as Prognostic Factor in NSCLC

Programmed Death–Ligand 1 and Vimentin: A Tandem Marker as Prognostic Factor in NSCLC

In non-metastatic non-small-cell lung cancer (NSCLC), outcomes remain poor. Adjuvant chemotherapies provide a limited improvement in disease-free survival. Recent exploratory studies on early-stage NSCLC show that immunotherapy given according to Programmed Death−Ligand 1 expression genera...

Full description

Bibliographic Details
Main Authors: Julien Ancel, Philippe Birembaut, Maxime Dewolf, Anne Durlach, Béatrice Nawrocki-Raby, Véronique Dalstein, Gonzague Delepine, Silvia Blacher, Gaëtan Deslée, Christine Gilles, Myriam Polette
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Cancers
Subjects:
epithelial–mesenchymal transition
Programmed Death–Ligand 1
Non-Small-Cell Lung Cancer
vimentin
immune checkpoints
Online Access:https://www.mdpi.com/2072-6694/11/10/1411

Internet

https://www.mdpi.com/2072-6694/11/10/1411

Similar Items